An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
Clinical trial NCT02321046 · COMPLETED
Trial details
- NCT number
- NCT02321046
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-09-02
- Primary completion
- 2019-06-28
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.